Vera Salus Ricerca

Vera Salus Ricerca is an Italian biotechnology company dedicated to the research and development of innovative pharmaceutical compounds and nutraceuticals. Headquartered in Siracusa, Sicily, the firm focuses on drug discovery through the identification of bioactive molecules that target viral, inflammatory, and oncological pathways. The company gained significant recognition for its development of VSR-1, a therapeutic candidate aimed at preventing SARS-CoV-2 infection by blocking viral entry into host cells. Vera Salus Ricerca operates as a lean R&D entity, utilizing strategic collaborations with academic institutions to progress its pipeline. Its portfolio bridges the gap between natural product chemistry and advanced synthetic drug design.